ARTIKKELEITA BORRELIOOSISTA V. 2004

[Bb]

Lähettäjä: Soijuv Lähetetty: 4.6.2005 19:54

Borrelioosia käsitteleviä artikkeleita v. 2004:


Anderson AL. Arthropod pests and the diseases they carry: prevention in
community and athletic settings.
Athletic Ther Today 2004 May; 9(3): 16-21, 36-7, 72.

Anonymous. The choice of antibacterial agents to treat Lyme disease
should be based on the stage and organ involvement of the infection.
Drugs & Therapy Perspectives 2004 Jun; 20(6): 14-7.

Anonymous. When should you order a Lyme titer?
Evid Based Pract 2004 May; 7(4): 3-5.

Anonymous. Two cases of Lyme disease presenting with persistent headache.
Brown Univ Child Adolesc Psychopharmacol Update 2004 Apr; 6(4): 8.

Baker BC. Hospitalisation due to Lyme disease: case series in British
Forces Germany.
J R Army Med Corps 2004 Sep; 150(3): 182-6.

Benton PJ. Lyme disease: a hazard of an appointment to the United States.
J R Nav Med Serv 2004; 90(2): 77-81.

Bozsik BP. Prevalence of Lyme borreliosis.
Lancet 2004 Mar 13; 363(9412): 901.

Burke G. Hypersensitivity to ticks and Lyme disease risk.
Emerg Infect Dis 2005 Jan; 11(1): 36-41.

Carvounis PE. Orbital myositis associated with Borrelia burgdorferi
(Lyme disease) infection.
Ophthalmology 2004 May; 111(5): 1023-8.

Centers for Disease Control and Prevention (CDC). Lyme disease ? United
States, 2001-2002.
MMWR Morb Mortal Wkly Rep 2004 May 7; 53(17): 365-9.

Chalmers C. Ticks and Lyme disease.
Practice Nursing 2004 Aug; 15(8 ): 388-90.

Chang DJ. Guidelines for serologic testing for Lyme disease: when to test.
J Musculoskeletal Med 2004 Aug; 21(8 ): 420-2, 422C-D.

Cooper JD. Inaccurate information about Lyme disease on the Internet.
Pediatr Infect Dis J 2004 Dec; 23(12): 1105-8.

Dinser R. Antibiotic treatment of Lyme borreliosis: what is the evidence?
Ann Rheum Dis 2005 Apr; 64(4): 519-23.

Dupeyron A. Sciatica, disk herniation, and neuroborreliosis: a report of
four cases.
Joint Bone Spine 2004 Sep; 71(5): 433-7.

Eiffert H. Acute peripheral facial palsy in Lyme disease ? a distal
neuritis at the infection site.
Neuropediatrics 2004 Oct; 35(5): 267-73.

Ekerfet C. Lyme borreliosis in Sweden ? diagnostic performance of five
commercial Borrelia serology kits using sera from well-defined patient
groups.
APMIS 2004 Jan; 112(1): 74-8.

Fikrig E. Preferential presence of decorin-binding protein B (BBA25) and
BBA50 antibodies in cerebrospinal fluid of patients with neurologic Lyme
disease.
J Clin Microbiol 2004 Mar; 42(3): 1243-6.

Fleming RV. Pre-treatment and post-treatment assessment of the C(6) test
in patients with persistent symptoms and a history of Lyme borreliosis.
Eur J Clin Microbiol Infect Dis 2004 Aug; 23(8 ): 615-8.

Ghosh S. In situ diversification of the antibody repertoire in chronic
Lyme arthritis synovium.
J Immunol 2005 Mar 1; 174(5): 2860-9.

Gab DJ. Borrelia burgdorferi, host-derived proteases, and the
blood-brain barrier.
Infect Immun 2005 Feb; 73(2): 1014-22.

Hassler D. Disappearance of specific immune response after successful
therapy of chronic Lyme borreliosis.
Int J Med Microbiol 2004 Apr; 293(Suppl 37): 161-4.

Hendrickx G. Persistent synovitis in children with Lyme arthritis: two
unusual cases. An immunogenetic approach.
Eur J Pediatr 2004 Nov; 163(!1): 646-50.

Herrington JE. Risk perceptions regarding ticks and Lyme disease: a
national survey.
Am J Prev Med 2004 Feb; 26(2): 135-40.

Isro I. Isolated monolateral neurosensory hearing loss as a rare sign of
neuroborreliosis.
Neurol Sci 2004 Apr; 25(1): 30-3.

Johnson JL. Passive tick surveillance, dog seropositivity, and incidence
of human Lyme disease.
Vector Borne Zoonotic Dis 2004 Summer; 4(2): 137-42.

Johnson L. Treatment of Lyme disease: a medicolegal assessment.
Expert Rev Anti Infect Ther 2004 Aug; 2(4): 533-57.

Karadag B. Lyme carditis: restitutio ad integrum documented by cardiac
magnetic resonance imaging.
Cardiol Rev 2004 Jul-Aug; 12(4): 185-7.

Kisand KE. Serological description of Estonian patients with Lyme
disease: a comparison with control sera from endemic and non-endemic areas.
Int J Med Microbiol 2004 Apr; 293 (Suppl 37): 174-7.

Knisley J. Lyme disease: knowledge is the best prevention.
Nurse Pract 2004 Aug; 29(8 ): 34-45.

Kumar S. Managing acute monarthritis in primary care practice.
J Musculoskeletal Med 2004 Sep; 21(9): 465-72.

Liang FT. Protective niche for Borrelia burgdorferi to evade humoral
immunity.
Am J Pathol 2004 Sep; 165(3): 977-85.

Lipsker D. How accurate is a clinical diagnosis of erythema chronicum
migrans? Prospective study comparing the diagnostic accuracy of general
practitioners and dermatologists in an area where lyme borreliosis in
endemic.
Arch Dermatol 2004 May; 140(5): 620-1.

Lo Re V 3rd. Identifying the vector of Lyme disease.
Am Fam Physician 2004 Apr 15; 69(8 ): 1935-7.

Martin AN. Don?t let the bad bugs bite.
Better Nutrition 2004 Apr; 66(4): 66-9.

McCabe GJ. Precipitation and the occurrence of Lyme disease in the
northeastern United States.
Vector Borne Zoonotic Dis 2004 Summer; 4(2): 143-8.

McKenna D. Factors influencing the utilization of Lyme disease
prevention behaviors in a high-risk population.
J Am Acad Nurse Pract 2004 Jan; 16(1): 24-30.

Meurs L. Acute transverse myelitis as a main manifestation of early
stage II neuroborreliosis in two patients.
Eur Neurol 2004; 52(3): 186-8.

Monroe J. Lyme disease: don?t hide inside this summer.
Current Health 1 2004 Feb; 27(6): 29-31.

Mulleger RR. Dermatological manifestations of Lyme borreliosis.
Eur J Dermatol 2004 Sep-Oct; 14(5): 296-109.

Nahimana I. Risk of Borrelia burgdorferi infection in western
Switzerland following a tick bite.
Eur J Clin Microbiol Infect Dis 2004 Aug; 23(8 ): 603-8.

Ostberg Y. The etiological agent of Lyme disease, Borrelia burgdorferi,
appears to contain only a few small RNA molecules.
J Bacteriol 2004 Dec; 186(24): 8472-7.

Pauluzzi P. Detection of spirochaetal DNA simultaneously in skin
biopsies, peripheral blood and urine from patients with erythema migrans.
Acta Derm Venereol 2004; 84(2): 106-10.

Peltomaa M. The V1sE (IR6) peptide ELISA in the serodiagnosis of Lyme
facial paralysis.
Otol Neurotol 2004 Sep; 25(5): 838-41.

Ramsey AH. Appropriateness of Lyme disease serologic testing.
Ann Fam Med 2004 Jul-Aug; 2(4): 341-4.

Randolph SE. Evidence that climate change has caused ?emergence? of
tick-borne diseases in Europe?
Int J Med Microbiol 2004 Apr; 293(Suppl 37): 5-15.

Re VL III. Photo essay: identifying the vector of Lyme disease.
Am Fam Physician 2004 Apr 15; 69(8 ): 1935-7 passim.

Rosa PA. The burgeoning molecular genetics of the Lyme disease spirochaete.
Nat Rev Microbiol 2005 Feb; 3(2): 129-43.

Schardt FW. Clinical effects of fluconazole in patients with
neuroborreliosis.
Eur J Med Res 2004 Jul 30; 9(7): 334-6.

Schmitz G. Unusual musculoskeletal manifestations of Lyme disease.
JBR-BTR 2004 Sep-Oct; 87(5): 224-8.

Singh SK. Molecular survival strategies of the Lyme disease spirochete
Borrelia burgdorferi.
Lancet Infect Dis 2004 Sep; 4(9): 575-83.

Singh SK. Lyme borreliosis: from infection to autoimmunity.
Clin Microbiol Infect 2004 Jul; 10(7): 598-614.

Stanek G. Lyme borreliosis.
Lancet Infect Dis 2004 Apr; 4(4): 197-9.

Steere AC. The emergence of Lyme disease.
J Clin Invest 2004 Apr; 113(8 ): 1093-1101.

Steere AC. Elucidation of Lyme arthritis.
Nat Rev Immunol 2004 Feb; 4(10: 143-52.

Stefancikova A. Anti-Borrelia antibodies in rodents: important hosts in
ecology of Lyme disease.
Ann Agric Environ Med 2004; 11(2): 209-13.

Stricker RB. Treatment of early Lyme disease.
Ann Intern Med 204 Apr 6; 140(7): 577-8.

Tsao JI. An ecological approach to preventing human infection:
vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle.
Proc Natl Acad Sci U S A 2004 Dec 28; 101(52): 18159-64.

Whelan M. Lyme disease in North America: a review.
Can J Infect Control 2004 Summer; 19(2): 80-6.

Widhe M. Borrelia-specific interferon-gamma and interleukin-4 secretion
in cerebrospinal fluid and blood during Lyme borreliosis in humans:
association with clinical outcome.
J Infect Dis 2004 May 15; 189(10): 1881-91.